Comparison of Loteprednol With Fluorometholone After Myopic Photorefractive Keratectomy

Comparison of Loteprednol With Fluorometholone After Myopic Photorefractive Keratectomy Publisher

Karimian F^{1, 2} ; Faramarzi A^{1, 2} ; Fekri S^{1, 2} ; Mohammadrabie H^{1, 3} ; Najdi D³ ; Doozandeh A^{1, 3} ; Delfazabaher S^{1, 3} ; Yaseri M⁴

Show Affiliations

1. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3. Torfeh Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4. Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Ophthalmic and Vision Research Published:2017

Abstract

Purpose: To compare the efficacy and side effects of loteprednol versus fluorometholone after myopic photorefractive keratectomy (PRK). Methods: One hundred and twenty four eyes of 62 patients who underwent PRK were enrolled in this study. One eye of each subject was randomized to receive loteprednol 0.5% and the fellow eye was given fluorometholone 0.1%. Patients were followed up for three months. Results: There was no significant difference in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction, corneal haze, intraocular pressure (IOP), and ocular discomfort and redness between groups at the final visit. At 3 months postoperatively, 20/25 or better UDVA was achieved in 95% of the loteprednol group and 92% of the fluorometholone group (P > 0.05). There was neither visually significant corneal haze nor ocular hypertension (IOP rise > 10 mmHg or IOP > 21 mmHg) in any group. Conclusion: The efficacy and side effects of loteprednol 0.5% and fluorometholone 0.1% after myopic PRK are comparable.

Style	Citing Format
MLA	Karimian F, et al.. "Comparison of Loteprednol With Fluorometholone After Myopic Photorefractive Keratectomy." Journal of Ophthalmic and Vision Research, vol. 12, no. 1, 2017, pp. 11-16.
APA	Karimian F, Faramarzi A, Fekri S, Mohammadrabie H, Najdi D, Doozandeh A, Delfazabaher S, Yaseri M (2017). Comparison of Loteprednol With Fluorometholone After Myopic Photorefractive Keratectomy. Journal of Ophthalmic and Vision Research, 12(1), 11-16.
Chicago	Karimian F, Faramarzi A, Fekri S, Mohammadrabie H, Najdi D, Doozandeh A, Delfazabaher S, Yaseri M. "Comparison of Loteprednol With Fluorometholone After Myopic Photorefractive Keratectomy." Journal of Ophthalmic and Vision Research 12, no. 1 (2017): 11-16.
Harvard	Karimian F et al. (2017) 'Comparison of Loteprednol With Fluorometholone After Myopic Photorefractive Keratectomy', Journal of Ophthalmic and Vision Research, 12(1), pp. 11-16.
Vancouver	Karimian F, Faramarzi A, Fekri S, Mohammadrabie H, Najdi D, Doozandeh A, et al.. Comparison of Loteprednol With Fluorometholone After Myopic Photorefractive Keratectomy. Journal of Ophthalmic and Vision Research. 2017;12(1):11-16.
BibTex	@article{ author = {Karimian F and Faramarzi A and Fekri S and Mohammadrabie H and Najdi D and Doozandeh A and Delfazabaher S and Yaseri M}, title = {Comparison of Loteprednol With Fluorometholone After Myopic Photorefractive Keratectomy}, journal = {Journal of Ophthalmic and Vision Research}, volume = {12}, number = {1}, pages = {11-16}, year = {2017} }
RIS	TY - JOUR AU - Karimian F AU - Faramarzi A AU - Fekri S AU - Mohammadrabie H AU - Najdi D AU - Doozandeh A AU - Delfazabaher S AU - Yaseri M TI - Comparison of Loteprednol With Fluorometholone After Myopic Photorefractive Keratectomy JO - Journal of Ophthalmic and Vision Research VL - 12 IS - 1 SP - 11 EP - 16 PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract